APA (7th ed.) Citation

Hopkins, P. N., Defesche, J., Fouchier, S. W., Bruckert, E., Luc, G., Cariou, B., . . . Swergold, G. D. (2015). Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody. Circulation. Cardiovascular genetics, 8(6), 823-831. https://doi.org/10.1161/CIRCGENETICS.115.001129

Chicago Style (17th ed.) Citation

Hopkins, Paul N., et al. "Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody." Circulation. Cardiovascular Genetics 8, no. 6 (2015): 823-831. https://doi.org/10.1161/CIRCGENETICS.115.001129.

MLA (9th ed.) Citation

Hopkins, Paul N., et al. "Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody." Circulation. Cardiovascular Genetics, vol. 8, no. 6, 2015, pp. 823-831, https://doi.org/10.1161/CIRCGENETICS.115.001129.